On February 18, 2016, the FDA issued a final order which will require the submission of premarket approval (PMA) applications for metal-on-metal (MoM) total hip replacement devices, which are hip implants where the "ball and socket" of the device are both made from metal. The devices included in this order are:
The Agency decided to increase its regulatory requirements for these devices after determining that, “given to the known risks, there is insufficient evidence and information to conclude that general controls in combination with special controls would provide reasonable assurance of the safety and effectiveness of these devices.” As such, FDA also stated that it will continue classifying these devices as high risk, and they will therefore remain class III medical devices.
Manufacturers are required to submit PMAs by May 18, 2016 in order to continue selling applicable devices that are currently being marketed, and/or to begin marketing new MoM total hip replacement devices. In its final order, the Agency stated that the following information must be included in PMA submissions sent to the FDA:
For additional information, view the final order issued by the FDA.
Do you have a medical device subject to these regulatory requirements? We can help ensure that your medical device, as well as any other FDA-regulated product, is compliant with all requirements. To learn more about our services and how we can help you, contact us today.
February 23, 2016
In 2020, the European Commission (EC) requested EMA and European Food Safety Authority (EFSA) for advice for the development of a harmonised approach on exposure assessment methodologies for residues...
February 23, 2016
JUNE 2022 EMA/278419/2022-Rev.1 This validation checklist is used by the Agency to validate initial marketing authorization applications for pharmaceuticals and applicants should use it as a means to...